A First-in-Human Dose Escalation Study of JNJ-79635322, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503679-12-00

Acronym

79635322MMY1001

Enrollment

Registered

2023-08-09

Start date

2022-11-21

Completion date

Unknown

Last updated

2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Previously Treated AL Amyloidosis, Relapsed or Refractory Multiple Myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026